Recent studies have shown that tissue macrophages (MΦ) arise from embryonic progenitors of the yolk sac (YS) and fetal liver and colonize tissues before birth. Further studies have proposed that developmentally distinct tissue MΦ can be identified based on the differential expression of F4/80 and CD11b, but whether a characteristic transcriptional profile exists is largely unknown. Here, we took advantage of an inducible fate-mapping system that facilitated the identification of CD45 + c-kit
Introduction
Macrophages (MΦ) play an important role in maintaining tissue integrity and contribute to adaptive and innate immune responses. They are part of the mononuclear phagocyte system and were classically thought to derive from blood monocytes (van Furth & Cohn, 1968) . This concept prevailed for nearly half a century (Ginhoux & Jung, 2014) . Accumulating evidence, however, including recent studies using sophisticated fate-mapping approaches, has determined that some tissue MΦ and their precursors are established embryonically in the yolk sac (YS) and fetal liver before the onset of hematopoiesis in the bone marrow (Ginhoux et al, 2010; Hoeffel et al, 2012; Schulz et al, 2012; Epelman et al, 2014; Molawi et al, 2014; Gomez et al, 2015) . However, conflicting reports have recently been published suggesting a different origin for all tissue macrophages except microglia from sources of the definitive hematopoiesis (Sheng et al, 2015) . Thus, the origin of tissue macrophages still awaits its full discovery. We therefore adapted our recently established Cx3cr1
CreER fate-mapping system Yona et al, 2013) to unequivocally determine the temporal and spatial origin of tissue macrophages and to investigate their full transcriptional program during ontogeny from the YS until adulthood.
Regardless of their origin, tissue MΦ can maintain themselves in adulthood through self-renewal and thus independently of blood monocytes (Ajami et al, 2007; Mildner et al, 2007; Hashimoto et al, 2013; Sieweke & Allen, 2013; Yona et al, 2013) . Recent studies have further proposed that the expression levels of the markers F4/80 and CD11b can be used to identify ontogenetically distinct MΦ populations in various tissues, but failed to determine genetic traits underlying this supposed heterogeneity (Schulz et al, 2012; Bain et al, 2014) . Previous gene expression profiling of MΦ populations from several tissues has established that only a small number of mRNA transcripts were associate with all MΦ but not DCs. However, a core gene signature of all macrophages could be detected (Gautier et al, 2012) . The impact of the tissue environment on MΦ signatures is now beginning to be unraveled. Epigenetic modifications are one of the conduits through which the organspecific environment can influence the established MΦ identities. The chromatin landscape, among other epigenomic features of a differentiated cell type, reflects both its developmental origin as well as its future potential. Two recent studies compared the tissue MΦ enhancer repertoire that revealed a tissue-specific signature with considerable plasticity (Gosselin et al, 2014; Lavin et al, 2014) .
However, the regulatory networks, the precise ancestry, and the mechanisms that describe tissue MΦ development from the YS stage to adulthood are largely unknown. By combining large-scale transcriptome profiling with fate mapping, immunophenotyping, and confocal imaging, we provide a detailed description of F4 ) in the YS to embryonic MΦ and then fully differentiated MΦ during adulthood. By using an A2 cell type-based fate-mapping system that tracks distinct YS cells, we can furthermore show that in contrast to a recent report (Sheng et al, 2015) several tissues contain F4/80 hi MΦ that are derived from the YS. Moreover, besides anticipated tissue environment-related genetic differences, we could identify a core signature in the embryonic and adult F4/80 hi and CD11b hi MΦ population. We further identified a transcriptional factor that is essential for both F4/80 hi and CD11b hi MΦ homeostasis in vivo. There are several transcription factors proven to be important for myeloid cell development including Pu.1, which affects multiple lineages of the hematopoiesis in an early stage including the development of MΦ (Rosenbauer & Tenen, 2007) . Additional transcription factors have been reported to play a role in the differentiation of myeloid cells such as interferon regulatory factor (Irf) 8 as a transcriptional factor of the IRF family (Rosenbauer & Tenen, 2007) . IRF-8 interacts with other transcription factors such as IRF-1, IRF-2, IRF-4 and PU.1 (Tamura & Ozato, 2002) . It is known that Irf8 has critical roles in the differentiation of myeloid cells, promoting monocyte over granulocyte differentiation (Tamura & Ozato, 2002) . It is also a crucial regulator of many aspects of DC development, differentiation, and function (Tamura et al, 2008) , thus holding an essential role in the establishment of innate immune responses. Although Irf8 is critical for the regulation of several myeloid cell lineages derived from hematopoietic stem cells (HSCs) including bone marrow-derived macrophages (Tamura & Ozato, 2002) , its role for tissue macrophages emerged from prenatal precursors from the YS or fetal liver, independent from HSCs, is unclear. In fact, recent work proposed a vital role of IRF-8 only for circulating monocytes but not for tissue macrophages (Hambleton et al, 2011) . In contrast to that report we show that both MΦ subsets (F4/80 hi and CD11b hi ) are strongly dependent on the transcription factor Irf8, which in our study influenced MΦ homeostasis. Our findings substantially increase the understanding of the regulatory processes that characterize tissue MΦ development in a highly dynamic microenvironment from the YS stage until adulthood.
Results
Temporospatial in vivo fate mapping and transcriptomics defines F4/80 hi MΦ as descendants of A2 progenitors
In mice, the first hematopoietic progenitors appear in the extraembryonic YS where they generate nucleated erythrocytes and MΦ starting at embryonic day (E) 7.5-8.0 (Bertrand et al, 2005; Cumano & Godin, 2007) . From E 8.0, multilineage erythromyeloid progenitors (EMPs) emerge in the YS as a second wave that are thought to give rise to tissue MΦ in the brain Prinz & Priller, 2014) and other tissues as well (Gomez et al, 2015) . After E 9.0, the intra-embryonic mesoderm commits to the hematopoietic lineage and new waves of hematopoietic progenitors emerge: first in the para-aortic splanchnopleura (P-Sp) region and then in the aorta-gonad-mesonephros (AGM) region (Cumano & Godin, 2007) .
To follow the fate of myeloid cells during early embryogenesis, we first used Cx3cr1 GFP/WT mice, which have a GFP knock-in on one allele of the Cx3cr1 gene. CX 3 CR1 is expressed in mature monocytes as well as many tissue MΦ and their precursors . To determine at which time point the YS contains progenitor cells with MΦ features, we analyzed E 9.0 embryos by thorough confocal microscopy ( Fig 1A and B (Bertrand et al, 2005; Kierdorf et al, 2013) (Fig 1C) . From our previous studies, we know that microglia derive from the A2 progenitors of the YS . Recently, it was suggested that the progenitor for microglia and other tissue MΦ are different from each other (Hoeffel et al, 2015; Sheng et al, 2015) . However, our hypothesis was that F4/80 hi MΦ derive from the A2 progenitors of the YS as well. To perform fate mapping and subsequent gene profiling of tissue MΦ during ontogeny, we next adapted our recently developed Cx3cr1 CreER mouse system Yona et al, 2013) to target A2 progenitors only (Fig 1D) . Male Cx3cr1
CreER : Rosa26-fl-STOP-fl-yfp (Cx3cr1
CreER :Rosa26-yfp) mice were crossed to female wild-type mice, and plug-positive animals were injected with a single intraperitoneal dose of tamoxifen (TAM) at E 9.0. The application of TAM at E 9.0 induced the recombination of CX 3 CR1 + progenitor cells and therefore also targeted A2-derived microglia (Fig EV1A and B) . Importantly, to prove the specificity of our approach, we additionally investigated the recombination efficiency in microglia of E 16.0 embryos after TAM application at E 7.0 and E 8.0 (Fig EV1B) . TAM application at E 8.0 but not at E 7.0 was able to target a small population of A2-derived microglia (YFP The EMBO Journal Irf8 and macrophage maturation Nora Hagemeyer et al were present in the E 10.0/E 10.5 AGM or fetal liver proving that we do not target HSCs in our approach (Fig EV1C and D) . Therefore, specific targeting of A2 progenitors by TAM injection at E 9.0 induced efficient YFP labeling of 41.6 AE 0.6% brain microglia, 20. (Fig 1F) . Microglia in 6-week-old animals retained the YFP label, demonstrating that A2-derived cells persists until adulthood, whereas labeling of Kupffer cells, Langerhans cells, and F4/80 hi kidney cells was present but dropped after birth (Figs 1E and F, EV1E and EV2) . This might be due to a replacement by fetal liver-derived cells as suggested by others (Hoeffel et al, 2012; Gomez et al, 2015) . In contrast, CD11b hi tissue MΦ were not labeled in this approach (Fig 1E and F) . Collectively, these data suggest that F4/80 hi tissue MΦ are initially derived from CX 3 CR1 + A2 cells in the YS, whereas CD11b hi tissue MΦ develop independently from A2 cells. After having established an A2 YS-dependent labeling system, we isolated EMP from E 8.0 YS, A1 and A2 cells from E 9.0 YS, and embryonic F4/80 hi MΦ from E 14.5 brain, liver, and kidney and performed a whole-genome expression analysis using the Affymetrix Mouse Gene 2.1 ST Array. Subsequent investigation of the 1,000 most variable transcripts by hierarchical clustering (Fig 1G) and generating a co-regulation network based on all expressed transcripts ( Fig 1H) revealed that EMPs represent an early step in MΦ hierarchy followed by the YS populations A1 and A2, while A2 cells obviously represent a nodal point of tissue MΦ development (Fig 1G and H) . These data suggest that the MΦ populations analyzed gain their own tissue-specific signature once they have left the YS and that A2 YS progenitors are ancestors of embryonic F4/80 hi tissue MΦ.
Difference in maintenance of F4/80 hi and CD11b hi MΦ after birth
Once established in the CNS, microglia persist throughout the entire life of the organism without any significant input from circulating blood cells due to their longevity and their capacity for self-renewal (Ajami et al, 2007; Mildner et al, 2007 Nora Hagemeyer et al Irf8 and macrophage maturation The EMBO Journal A2 progenitors in the YS, whereas CD11b hi MΦ seem to originate from later hematopoietic sources, for example, elements from the definitive hematopoiesis (Ginhoux & Jung, 2014) . Thus, we examined whether this divergent origin is mirrored by a distinct gene profile. To do so, we performed an unsupervised clustering analysis of genomewide expression arrays from embryonic ( Fig 3A) and adult ( Fig 3B) F4/80 hi MΦ in comparison with the CD11b hi populations.
Hierarchical clustering based on the 1,010 most differentially expressed genes revealed that all F4/80 hi MΦ in the brain, liver, and kidney shared a common signature of expressed genes, which was clearly distinct from the CD11b hi cells. Importantly, F4/80 hi versus CD11b hi MΦ clustering was not only present prior to birth as described recently (Schulz et al, 2012) but was still detectable in adulthood ( Fig 3A and B) . Based on the clear cut separation of F4/ 80 hi versus CD11b hi MΦ by hierarchical cluster analyses, we created two groups, including only the embryonic or adult F4/80 hi (microglia, liver and kidney) or CD11b hi (liver and kidney) MΦ and excluded genes that were significantly differentially expressed within one of the groups (Fig 3C and D) . This approach confirmed the hypothesis of robust similarities within MΦ subgroups rather than within different MΦ populations in the same organ ( Fig 3D) . Notably, only adult Langerhans cells were transcriptionally separate from both adult F4/80 hi and CD11b hi MΦ in other tissues emphasizing their distinct ancestry and kinetics compared to other MΦ as 
A Scheme of fate mapping in Cx3cr1
CreER :R26-yfp mice that were either treated at 6 weeks of age (for B) or at postnatal day 1 (for C) and analyzed at 6 days, 2, 4, and 35 weeks (for B) and 6 days, 6 and 35 weeks (for C). B, C Flow cytometric quantifications of YFP + MΦ in the brain, liver, and kidney at the indicated time points after TAM application in Cx3cr1 CreER :R26-yfp mice. Data are summarized from two independent experiments (7-8 mice each) and represented as mean AE s. In addition to CSF-R1, several transcription factors such as PU.1 (encoded by Sfpi) and Runx1 have been shown to be important for the lineage commitment in myeloid cells (Rosenbauer & Tenen, 2007) . It is well established that PU.1 can act alone or in association with other transcription factors such as IRF8 (Rosenbauer & Tenen, 2007) . To determine which transcription factors are present during macrophage development, we measured Runx1, Sfpi, and Irf8 levels in sorted EMP, A1 and A2 cells, embryonic microglia, and F4/80 hi and CD11b hi MΦ from kidney and liver ( Fig 4A) . Irf8 and Sfpi were barely detectable in EMP, whereas Runx1 was strongly expressed. Notably, Irf8, Runx1, and Sfpi mRNA levels were continuously expressed during prenatal macrophage development, suggesting that these transcription factors play an important role for these macrophage populations. Since Irf8 was described to play an essential role in the development of microglia, especially in the maturation of the A1 to A2 progenitor populations in the YS , we hypothesized that Irf8 might also be required for other YS-derived F4/80 hi MΦ populations. As expected, in the E 9.0 YS especially A2 cells expressed IRF8 as visualized in Irf8-VENUS PAC reporter mice (Fig 4B) . We next determined whether IRF8 expression is strictly developmentally regulated or whether it is also expressed in adult MΦ during homeostasis (Fig 4C and D) . Microglia constantly expressed high levels of IRF8 from embryogenesis until adulthood (Fig 4C) . Notably, CD11b hi and F4/80 hi MΦ in the liver and kidney were strongly positive for the Irf8-VENUS signal suggesting an essential role of this transcription factor for MΦ maintenance.
Irf8 regulates tissue MΦ homeostasis
To assess the function of IRF8 in MΦ under steady-state conditions during adulthood, we used Irf8 À/À mice to quantify the number of MΦ in brain, liver, and kidney and performed a thorough morphometric analysis of these cell populations (Fig 5) . Irf8-deficient microglia exhibited drastic changes in their morphology including a significant decrease in their dendritic branching, assessed by filament length and number of dendrite terminal points per cell, whereas the cell number was increased (Fig 5A) . Similarly, liver MΦ in Irf8 À/À mice were characterized by a significantly reduced cell surface and volume as well as cell number (Fig 5B) . In contrast, the number of kidney MΦ was significantly reduced by Irf8 deficiency; the morphometric parameters, however, were unchanged ( Fig 5C) . Despite these severe effects on tissue MΦ, the organ function of the liver and kidney under homeostatic conditions was unimpaired in Irf8-deficient animals (Fig EV4) . +/+ and Irf8 À/À mice was higher in the embryonic compared to the adult MΦ cell populations (Fig 6A) . Moreover, Irf8 deficiency had an influence on the transcriptional pattern of both F4/80 hi and CD11b hi MΦ populations (Fig 6A-C) . A Quantitative qRT-PCR of transcription factors during MΦ development. Data are normalized to b-actin and GAPDH and expressed as ratio of the mRNA expression compared to embryonic microglia and show mean AE s.e.m. Two to three mice per group were analyzed. B Irf8-VENUS expression on A1 and A2 progenitor cells isolated from the E 9.0 yolk sac of Irf8-Venus PAC reporter mice. Representative blots obtained from 17 individual embryos are shown. Mean fluorescence intensity (MFI) of Irf8-VENUS signal in A1 and A2 progenitor cells. Each symbol represents one mouse. Data are from one representative experiment out of two and represented as mean AE s.e.m. C Flow cytometric measurement of the Irf8-VENUS signal in brain, liver, and kidney MΦ from E 14.0, postnatal (P1), and adult (P42) Irf8-VENUS PAC reporter mice.
Representative density blots are shown (left) and quantification thereof (right (Fig 6D) . Obviously, genes related to the immune system were down-regulated in all Irf8 À/À MΦ populations suggesting an impact of IRF8 on the immune response of these cells. Quantitative RT-PCR performed with the adult MΦ populations confirmed this finding by showing a down-regulation of Toll-like receptor 12 (Tlr12), major histocompatibility complex class II, DM alpha (H2-DMa), and basic leucine zipper transcription factor and ATF-Like 3 (Batf3) in Irf8 À/À F4/80 hi MΦ (Fig 6E) . Moreover, Cd36, Fc fragment of IgG, high affinity Ia, receptor (Fcgr1 also known as Cd64), and Irf7 were down-regulated in Irf8 À/À CD11b hi MΦ (Fig 6E) . All of these genes are involved in immune response or regulation of type I interferons. Suppression of MHC class II expression on Irf8 À/À MΦ was additionally confirmed by immunohistochemistry (Fig EV5) . In sum, these data provide clear evidence for an essential role of IRF8 The EMBO Journal Irf8 and macrophage maturation Nora Hagemeyer et al this view was recently challenged by a study claiming that only microglia are YS-derived, whereas all other tissue MΦ are fetal liverderived (Sheng et al, 2015) . In contrast, our data do not support the idea of a complete fetal liver origin of all tissue F4/80 hi MΦ except microglia but instead confirm earlier reports on the YS origin of most F4/80 hi tissue MΦ (Schulz et al, 2012; Gomez et al, 2015) .
These studies provided clear evidence that EMPs, localized in the YS, are the non-committed progenitors of tissue MΦ. Our own data add exciting new facets to the YS origin of tissue MΦ. Using a new fate-mapping strategy in Cx3cr1
CreER :Rosa26-yfp mice combined with transcriptional analysis, we place the A2-progenitor population of the YS as the direct precursors of microglia and partially F4/80 hi MΦ in the liver and kidney as well as Langerhans cells. By confocal microscopy of E 9.0 and E 10.0/10.5 embryos and the E 9.0 YS, we proved that CX 3 CR1 + cells are exclusively present in the YS but not in the P-Sp/AGM or fetal liver at these time points and are therefore the only progenitor cells which are targeted by our fatemapping strategy. Additionally, our results show that, except for microglia, the YS-derived F4/80 hi MΦ population in the liver and kidney as well as Langerhans cells was decreased during development suggesting a second source for these cell populations. These data support the previous findings that YS-derived Langerhans cell precursors are potentially replaced by fetal liver-derived HSCs and therefore present the main source of the adult Langerhans cells (Hoeffel et al, 2012 Nora Hagemeyer et al Irf8 and macrophage maturation The EMBO Journal liver and kidney were not targeted by our fate-mapping strategy demonstrating their origin from definitive hematopoiesis. Our data stand in contrast to a recent publication, which claims an exclusive origin of all MΦ from the fetal liver (Sheng et al, 2015) . Even though a contribution of bone marrow-derived HSCs to F4/80 hi kidney MΦ was previous suggested (Schulz et al, 2012) , the maintenance and turnover of these cells as well as of F4 /80 hi Kupffer cells and CD11b hi liver MΦ were so far not investigated.
Using adult Cx3cr1
CreER :Rosa26-yfp mice, we could identify a low but constant turnover rate for F4/80 hi kidney MΦ in contrast to a high turnover rate for CD11b hi MΦ. To bypass the downregulation of CX 3 CR1 expression in F4/80 hi Kupffer cells during postnatal life, we directly targeted these cells after birth. So far, it was only shown indirectly that Kupffer cells have apparently no contribution from blood monocytes using either Ccr2-deficient (Bain et al, 2014) or parabiotic mice under homeostatic conditions (Epelman et al, 2014) . However, a contribution of blood monocytes to F4/80 hi Kupffer cells under disease conditions or after depletion was recently suggested (Bleriot et al, 2015; Scott et al, 2016) . Our results provide therefore the first direct genetic proof that at least a subpopulation of the Kupffer cells has no turnover from birth until 9 months of age under steady-state conditions. Recently, Clec4 has been identified as a specific gene for Kupffer cells (Scott et al, 2016) and this might open new possibilities to further study explicitly this cell population in future. A broad transcriptional analysis of different tissue MΦ populations revealed that MΦ gene expression is strongly dependent on the specific organ environment (Gautier et al, 2012) . Moreover, separation of embryonic F4/80 hi and CD11b hi tissue MΦ by gene expression pattern was previously suggested (Schulz et al, 2012) . In the present study, we additionally performed transcriptional microarray analysis of embryonic and adult F4/80 hi and CD11b hi tissue MΦ including microglia and adult Langerhans cells. Despite organspecific expression patterns (data not shown), we identified robust similarities of F4/80 hi versus CD11b hi MΦ across organs which were present prenatally and in adulthood. Interestingly, only Langerhans cells were transcriptionally separated from both the adult F4/80 hi and CD11b hi MΦ indicating that they represent a unique tissue MΦ population. Of note, we defined signature genes for tissue macrophages based on a previous analysis (Lavin et al, 2014) using linear support vector regression implemented in CIBERSORT (Newman et al, 2015) and could demonstrate that microglia and Kupffer cells in our analysis were mainly characterized by the same signature genes (data not shown). This suggests that our sorting strategy was compatible with previous approaches to determine tissue macrophages. PU.1 has been described as a key regulator of myeloid/macrophage development for a long time, reflected by a complete absence of mature macrophages in Pu.1-deficient animals (McKercher et al, 1996) . In contrast, Irf8 was only described as a transcription factor regulating myeloid and lymphoid maturation (Holtschke et al, 1996; Hambleton et al, 2011) . More recently, we described that Irf8 is essential for the maturation of the YS A1-to A2-progenitor populations Shiau et al, 2015) . The importance of Irf8 for microglia from the early wave of hematopoiesis was also observed in zebrafish (Shiau et al, 2015) . Interestingly, in their study, the impact on peripheral MΦ was limited to the embryonic stage, whereas the effect on microglia was long-lasting. However, Moreover, we found that Irf8 is crucial for proper maturation of microglia as well as liver and kidney MΦ.
Materials and Methods

Mice
Cx3cr1
GFP/WT , Cx3cr1
CreER :R26-yfp (Jung et al, 2000; Yona et al, 2013) , Ccr2 À/À (Boring et al, 1997) , Nr4a1 Holtschke et al, 1996) ; Irf8-VENUS (Schonheit et al, 2013) Ccr2 RFP/WT were described elsewhere. All mice including the corresponding wild-type controls were bred in-house and were housed in specific pathogenfree conditions. Experiments were performed with 6-to 10-week-old female and male mice, if not stated otherwise. All mouse experiments were performed in accordance with the animal law and guidelines. PAC-transgenic Irf8-Venus mice were kindly provided by Frank Rosenbauer (Medical Faculty of the WWU Mü nster, Germany), Nr4a1 À/À mice by Antigoni Triantafyllopoulou (University Hospital Freiburg, Germany), and Ccr2 RFP/WT mice by Mathias Jucker (German Center for Neurodegenerative Diseases, Tü bingen, Germany).
Timed matings
Timed matings were used to analyze embryonic mice. The matings were started in the afternoon and separated after plug check on the following morning. Embryonic development was estimated considering the day of vaginal plug formation as embryonic day (E) 0.5 and staged by developmental criteria. The EMP was isolated at E 8.0, A1 and A2 at E 9.0, embryonic macrophage populations at E 14.5, and adult macrophage populations at postnatal day (P)42.
Tamoxifen induction
Tamoxifen (TAM, Sigma-Aldrich, Taufkirchen, Germany) was dissolved in corn oil (Sigma-Aldrich, Taufkirchen, Germany) to get a 20 mg/ml solution for injections. Six-week-old Cx3cr1
CreER : Rosa26-yfp mice were subcutaneously injected with 4 mg TAM on The EMBO Journal Irf8 and macrophage maturation Nora Hagemeyer et al 2 days (day 0 and 2). For Cre induction in the newborn mice, intraperitoneal (i.p.) injection of 0.1 mg TAM was performed at P1. For pulse labeling experiments, plug-positive Cx3cr1
CreER :Rosa26-yfp females from timed matings were i.p. injected with 3 mg TAM (20 mg/ml TAM + 10 mg/ml Progesterone; Sigma-Aldrich, Taufkirchen, Germany) at E 9.0, E 8.0, or E 7.0.
Preparation of tissue samples
Mice were lethally anesthetized with ketamine (100 mg/kg bodyweight, Medistar, Germany) and xylazine (5 mg/kg bodyweight, Bayer, Leverkusen, Germany) followed by the perfusion with 1× PBS through the left heart chamber. For histology, organs were transferred to 4% PFA. For the preparation of single-cell suspension for flow cytometry, brain, liver, and kidney were cut into small pieces. The tissue of the liver and kidney was transferred to enzymatic solutions (1 mg/ml collagenase D (Roche, Darmstadt, Germany) + 2.4 mg/ml dispase (Roche, Darmstadt, Germany) + 0.2 mg/ml DNase (Sigma-Aldrich, Taufkirchen, Germany) in 1× PBS for the liver and 1 mg/ml collagenase D in 1× PBS for the kidney) and incubated for 30 min at 37°C on a shaker. Cell suspensions were filtered through a mesh (100 or 70 lm, restrictively). The liver samples were centrifuged at 54 g for 3 min, 4°C. Supernatant was transferred to a new tube. Liver and kidney samples were centrifuged for 5 min 251 g, 4°C. Erythrocytes were removed by RBC lysis buffer (eBioscience, San Diego, USA). Brain tissue was homogenized and filtered through a 70 lm mesh. After centrifugation (10 min 251 g, 4°C), the pellet was resuspended in 70% Percoll (Sigma-Aldrich, Taufkirchen, Germany) and was underlay to a Percoll density gradient (30 and 37%). Density gradient centrifugation was performed for 30 min, 800 g at 4°C without brake. Microglia were collected from the interphase 70% to 37% Percoll. For skin samples, ears were separated and dermis was put on a 0.2 mg/ml dispase solution o/n 4°C, dermis and epidermis were separated, and the epidermis was cut in small pieces followed by enzymatic (1.5 mg/ml collagenase V, Life technologies, Darmstadt, Germany) digestion for 1.5 h at 37°C. Homogenates were filtered through a 100 lm mesh and centrifuged (251 g, 5 min, 4°C). Cell suspensions from isolated YS were obtained by mechanical homogenization, using passage through 22-25 gauge needles as described before (Bertrand et al, 2005) .
Flow cytometry
Cells were acquired on FACSCanto II and LSRFortessa systems (BD Bioscience, Heidelberg, Germany) and analyzed with Flowjo software (TreeStar). Cell sorting was performed on a MoFlo Astrios (Beckman Coulter, Krefeld, Germany). The following antibodies were used for staining cells: anti-CD45 (clone 30-F11, eBioscience, San Diego, USA), anti-CD11b (clone M1/70, eBioscience, San Diego, USA), anti-CD146 (clone ME-9F1, Biolegend, Fell, Germany), anti-CD3 (clone eBio500A2, eBioscience, San Diego, USA), anti-CD19 (clone eBio1D3, eBioscience, San Diego, USA), anti-NK1.1 (clone PK136, eBioscience, San Diego, USA), anti-Gr1 (clone Biolegend, Fell, Germany) 
Histology
For whole embryo imaging, E9.0 Cx3Cr1 GFP/+ embryos were fixed for 10 min in 4% paraformaldehyde and processed for whole-mount immunolabeling, using F4/80-APC (Clone BM8, eBioscience, San Diego, USA) or c-kit-APC (Clone 2B8, eBioscience, San Diego, USA), CD41-AF647 (Clone eBioMWReg30, Molecular Probes, Eugen, Oregon, USA), and CD31-PE (Clone Mec13.3, BioLegend, Fell, Germany) antibodies, as previously described (Bertrand et al, 2005) . Whole embryos or isolated YS were placed in the central well of glass bottom culture dishes (P35G-1.5-10-C, from MatTek, USA) filled with PBS + 10% fetal calf serum. After appropriate orientation of the sample, the well was covered with a 12-mm coverslip glass. Image stacks were collected using a Leica SP8 confocal microscope. Images were processed using Fiji and PHOTOSHOP 8. 
Pre-processing of gene expression data
The Robust Multi-array Average (RMA) function was used to normalize the data during import of the raw Affymetrix data (CEL files) of a total of 81 samples into Partek Genomics Suite (PGS). The background value was defined as the median of the entire normalized dataset using all probes. Gene probes were only kept for further analysis if their mean expression values were higher than the background in at least one group or condition within the whole dataset. Next, multiple probes for one gene locus were filtered allowing only one probe with the highest overall mean expression. These preprocessing steps resulted in 17,888 unique genes to be present in at least one group or condition. These genes were retained for further analyses.
Identification of differentially expressed genes and hierarchical clustering
Differentially expressed (DE) genes were defined in PGS by analysis of variance (ANOVA) models by setting certain fold change (FC) thresholds and false discovery rate [FDR, (Hochberg & Benjamini, 1990) ] adjusted P-value cutoffs to determine differences between two comparable groups, for example, cells derived from Irf8 
Co-regulation analysis by BioLayout Express3D
BioLayout Express3D (BioLayout) is a powerful tool for the visualization and analysis of network graphs based on co-expression (Theocharidis et al, 2009) . BioLayout was applied to discriminate different cell populations during embryonic MΦ development. Sample-sample correlation was calculated and transformed into 3D coordinates. A Pearson's correlation coefficient cutoff of 0.92 was used to keep stronger connections (higher correlation) between samples, and subsequently, the co-regulation network was constructed and visualized in 3D space. Gene Ontology (GO) enrichment analysis and GO network visualization. To link the data to prior knowledge, GO enrichment analysis was applied by using the Cytoscape plug-in BiNGO (v2.44) (Maere et al, 2005) . To include only significant results, the FDR q-value threshold was set to 0.05 as default. The Cytoscape plugins Enrichment Map (v1.1) (Merico et al, 2010) and Word Cloud (Oesper et al, 2011) were used to visualize the GO networks. To decrease the size of the networks and to define certain cutoffs for the similarity of GO terms, the default settings of Jaccard coefficients (0.25) and their FDR q-values (0.1) were utilized.
PCR array
For quantitative gene expression analysis, the RNA of FACS-sorted MΦ population was isolated as described above. Reverse transcription was performed using the RT 2 PreAMP cDNA Synthesis Kit (Qiagen, Germantown, USA) with a custom-made Primer-Mix according to manufacturer's instructions. RT-PCR was performed using a custom-made SABioscience PCR-Array (Qiagen, Germantown, USA) with the genes of interest and analyzed with a LightCycler 480 (Roche, Darmstadt, Germany). Beta-Actin and GAPDH were used as housekeeping genes. Analysis was performed using the online data analysis center from Qiagen.
Serum protein quantifications
Serum ALT was analyzed from whole blood using ALT strips from Roche according to the manufacturer's instructions. Measurement was performed in a Reflovet machine from SCIL animal care. Values above assay range were diluted prior to measurement. Serum creatinine was measured using an enzymatic colorimetric (ELISA) creatinine kit (Lehmann) following the manufacturer's instructions.
Bacterial load
Liver lobes from adult Irf8 À/À and Irf8 +/+ were dissected and weighted before bacterial DNA was isolated from the livers as described before (Wilson & Grenfell, 1997) . Quantitative PCR for 16sRNA gene was performed and normalized to the weight of the isolated tissue.
Statistical analysis
Statistical analysis was performed using GraphPad Prism (GraphPad Software, Version 6.0, La Jolla, USA). All data were tested for normality applying the F-test to compare variance. If normality was given, an unpaired t-test, two-sided was applied. If the data did not meet the criteria of normality, the Mann-Whitney U-test, two-sided was applied. Differences were considered significant when P-value < 0.05.
GEO accession numbers
The main GEO accession number for microarray: GSE73125.
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